您当前所在的位置:首页 > 产品中心 > 产品信息
Enoxolone_分子结构_CAS_471-53-4)
点击图片或这里关闭

Enoxolone

产品号 Bio-0549 公司名称 InterBioScreen
CAS号 471-53-4 公司网站 http://www.ibscreen.com
分子式 C30H46O4 电 话 +7 49652 40091
分子量 470.68384 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 72941

产品价格信息

请登录

产品别名

标题
Enoxolone
IUPAC标准名
(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid
IUPAC传统名
(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid
别名
Glycyrrhetinic acid
Glycyrrhetin
Biosone
Biogastrone acid
Uralenic acid
Glycyrrhetic acid
Rhetinic acid

产品登记号

CAS号 471-53-4

产品性质

应用领域 Antibacterial, antitussive agent
应用领域 Antiinflammatory
应用领域 Used in treatment of noninfective inflammatory disorders (skin, mouth, etc.)
生物来源 Aglycone from Glycyrrhiza glabra and some other plants
生物活性机理 Calcium-mobilizer in P815 cells in-vitro
生物活性机理 Reported to trap hydroxyl radicals to suppress rat liver injury caused by ischemia-perfusion
生物活性机理 Reported to inhibit reactive oxygen species generation by human neutrophils in-vitro

产品详细信息

参考文献

  • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 1057D, (ir)
  • Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 596A, (nmr)
  • Beaton, J.M. et al., J.C.S., 1955, 3126, (synth)
  • Mer, J., Am. Perfum. Aromat., 1959, 74, 39, (isol)
  • U.K. Pat., 1960, 843 133; CA, 55, 2027i, (Carbenoxolone)
  • Witz, P. et al., Bull. Soc. Chim. Fr., 1963, 1101, (cd)
  • Budzikiewicz, H. et al., J.A.C.S., 1963, 85, 3688, (ms)
  • Murav'ev, I.A. et al., CA, 1966, 69, 44029v, (rev)
  • Canonica, L. et al., Gazz. Chim. Ital., 1967, 97, 1347; 1968, 98, 602, (Glycyrrhetol)
  • Robson, J.M. et al., Carbenoxolone Sodium, Orig. Pap. Discuss. Group Meet., Butterworth, London, 1969, (rev)
  • Wahlberg, I. et al., Acta Chem. Scand., 1971, 25, 3192, (ms)
  • Sandiya, R. et al., J. Het. Chem., 1984, 21, 845, (isol)
  • Tolstikov, G.A. et al., Khim. Prir. Soedin., 1985, 21, 645; Chem. Nat. Compd. (Engl. Transl.), 1985, 21, 605, (cmr)
  • Sakano, K. et al., Agric. Biol. Chem., 1986, 50, 763, (deriv)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 7889; 8042, (synonyms)
  • Kanaoka, M. et al., Chem. Pharm. Bull., 1988, 36, 3264, (synth)
  • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 758; 873
  • Saito, S. et al., Chem. Pharm. Bull., 1994, 42, 1016, (synth)
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, GIE000; BGD000; GIEO5O; CBO500